Free Trial
OTCMKTS:RHHBY

Roche (RHHBY) Stock Price, News & Analysis

Roche logo
$40.51 +0.99 (+2.51%)
As of 04/28/2025 03:59 PM Eastern

About Roche Stock (OTCMKTS:RHHBY)

Key Stats

Today's Range
$39.91
$40.59
50-Day Range
$35.90
$44.24
52-Week Range
$29.20
$44.31
Volume
2.32 million shs
Average Volume
3.08 million shs
Market Capitalization
$258.37 billion
P/E Ratio
N/A
Dividend Yield
2.10%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Receive RHHBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.

RHHBY Stock News Headlines

3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.
3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S. (RHHBY)
See these three top-10 stocks in the pharmaceutical industry that are pledging investment in the United States totalling over $100 billion.
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Roche price target lowered to CHF 286 from CHF 312 at Morgan Stanley
See More Headlines

RHHBY Stock Analysis - Frequently Asked Questions

Roche's stock was trading at $34.88 at the start of the year. Since then, RHHBY stock has increased by 16.1% and is now trading at $40.51.
View the best growth stocks for 2025 here
.

The following companies are subsidiaries of Roche: Inflazome, Stratos Genomics, Promedior, Spark Therapeutics, Tusk Therapeutics, Flatiron Health, Ignyta, and others.

Top institutional shareholders of Roche include GAMMA Investing LLC (0.01%), Boston Common Asset Management LLC (0.01%), OLD National Bancorp IN and Altrius Capital Management Inc.

Shares of RHHBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
4/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:RHHBY
CIK
N/A
Employees
103,605
Year Founded
1896

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
14.42
P/E Growth
2.18
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$68.73 billion
Cash Flow
$3.16 per share
Price / Cash Flow
12.82
Book Value
$5.81 per share
Price / Book
6.97

Miscellaneous

Outstanding Shares
6,377,936,000
Free Float
N/A
Market Cap
$258.37 billion
Optionable
Not Optionable
Beta
0.48

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (OTCMKTS:RHHBY) was last updated on 4/29/2025 by MarketBeat.com Staff
From Our Partners